527 related articles for article (PubMed ID: 34937917)
1. NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury.
Xie ZY; Dong W; Zhang L; Wang MJ; Xiao ZM; Zhang YH; Shi WX; Huang Y; Yang Y; Li CL; Fu L; Zhao XC; Li RZ; Li ZL; Chen YH; Ye ZM; Liu SX; Dong Z; Liang XL
Acta Pharmacol Sin; 2022 Aug; 43(8):2081-2093. PubMed ID: 34937917
[TBL] [Abstract][Full Text] [Related]
2. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.
Zhang L; Li R; Shi W; Liang X; Liu S; Ye Z; Yu C; Chen Y; Zhang B; Wang W; Lai Y; Ma J; Li Z; Tan X
Br J Pharmacol; 2013 Sep; 170(2):426-39. PubMed ID: 23826864
[TBL] [Abstract][Full Text] [Related]
3. Knockout of Zeb2 ameliorates progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia-reperfusion injury.
Inotani S; Taniguchi Y; Nakamura K; Nishikawa H; Matsumoto T; Horino T; Fujimoto S; Sano S; Yanagita M; Terada Y
Nephrol Dial Transplant; 2022 Feb; 37(3):454-468. PubMed ID: 34724064
[TBL] [Abstract][Full Text] [Related]
4. A short treatment with resveratrol after a renal ischaemia-reperfusion injury prevents maladaptive repair and long-term chronic kidney disease in rats.
Martínez-Rojas MÁ; Balcázar H; Ponce-Nava MS; González-Soria I; Marquina-Castillo B; Pérez-Villalva R; Bobadilla NA
J Physiol; 2024 Apr; 602(8):1835-1852. PubMed ID: 38529522
[TBL] [Abstract][Full Text] [Related]
5. KLF4 initiates sustained YAP activation to promote renal fibrosis in mice after ischemia-reperfusion kidney injury.
Xu D; Chen PP; Zheng PQ; Yin F; Cheng Q; Zhou ZL; Xie HY; Li JY; Ni JY; Wang YZ; Chen SJ; Zhou L; Wang XX; Liu J; Zhang W; Lu LM
Acta Pharmacol Sin; 2021 Mar; 42(3):436-450. PubMed ID: 32647339
[TBL] [Abstract][Full Text] [Related]
6. Proximal Tubular
Zhang C; Zheng Z; Xu K; Cheng G; Wu H; Liu J
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894939
[TBL] [Abstract][Full Text] [Related]
7. Blockade of STAT3 signaling alleviates the progression of acute kidney injury to chronic kidney disease through antiapoptosis.
Park JY; Yoo KD; Bae E; Kim KH; Lee JW; Shin SJ; Lee JS; Kim YS; Yang SH
Am J Physiol Renal Physiol; 2022 May; 322(5):F553-F572. PubMed ID: 35311382
[TBL] [Abstract][Full Text] [Related]
8. Akt1 is involved in renal fibrosis and tubular apoptosis in a murine model of acute kidney injury-to-chronic kidney disease transition.
Kim IY; Song SH; Seong EY; Lee DW; Bae SS; Lee SB
Exp Cell Res; 2023 Mar; 424(2):113509. PubMed ID: 36773738
[TBL] [Abstract][Full Text] [Related]
9. 14-3-3ζ inhibits maladaptive repair in renal tubules by regulating YAP and reduces renal interstitial fibrosis.
Wang TT; Wu LL; Wu J; Zhang LS; Shen WJ; Zhao YH; Liu JN; Fu B; Wang X; Li QG; Bai XY; Wang LQ; Chen XM
Acta Pharmacol Sin; 2023 Feb; 44(2):381-392. PubMed ID: 35840657
[TBL] [Abstract][Full Text] [Related]
10. Cellular communication network factor 2 (CCN2) promotes the progression of acute kidney injury to chronic kidney disease.
Inoue T; Kusano T; Amano H; Nakamoto H; Okada H
Biochem Biophys Res Commun; 2019 Sep; 517(1):96-102. PubMed ID: 31320136
[TBL] [Abstract][Full Text] [Related]
11. The role of podocyte damage in the etiology of ischemia-reperfusion acute kidney injury and post-injury fibrosis.
Chen Y; Lin L; Tao X; Song Y; Cui J; Wan J
BMC Nephrol; 2019 Mar; 20(1):106. PubMed ID: 30922260
[TBL] [Abstract][Full Text] [Related]
12. VNN1 contributes to the acute kidney injury-chronic kidney disease transition by promoting cellular senescence via affecting RB1 expression.
Chen J; Lu H; Wang X; Yang J; Luo J; Wang L; Yi X; He Y; Chen K
FASEB J; 2022 Sep; 36(9):e22472. PubMed ID: 35959877
[TBL] [Abstract][Full Text] [Related]
13. Renal ischemia-reperfusion injury causes hypertension and renal perfusion impairment in the CD1 mice which promotes progressive renal fibrosis.
Greite R; Thorenz A; Chen R; Jang MS; Rong S; Brownstein MJ; Tewes S; Wang L; Baniassad B; Kirsch T; Bräsen JH; Lichtinghagen R; Meier M; Haller H; Hueper K; Gueler F
Am J Physiol Renal Physiol; 2018 May; 314(5):F881-F892. PubMed ID: 29357437
[TBL] [Abstract][Full Text] [Related]
14. A two-stage bilateral ischemia-reperfusion injury-induced AKI to CKD transition model in mice.
Zhang J; Wang X; Wei J; Wang L; Jiang S; Xu L; Qu L; Yang K; Fu L; Buggs J; Cheng F; Liu R
Am J Physiol Renal Physiol; 2020 Aug; 319(2):F304-F311. PubMed ID: 32567350
[TBL] [Abstract][Full Text] [Related]
15. Hippo-YAP/MCP-1 mediated tubular maladaptive repair promote inflammation in renal failed recovery after ischemic AKI.
Zheng Z; Li C; Shao G; Li J; Xu K; Zhao Z; Zhang Z; Liu J; Wu H
Cell Death Dis; 2021 Jul; 12(8):754. PubMed ID: 34330891
[TBL] [Abstract][Full Text] [Related]
16. Lrg1 silencing attenuates ischemia-reperfusion renal injury by regulating autophagy and apoptosis through the TGFβ1- Smad1/5 signaling pathway.
Chen J; Zhang Z; Feng L; Liu W; Wang X; Chen H; Zou H
Arch Biochem Biophys; 2024 Mar; 753():109892. PubMed ID: 38246328
[TBL] [Abstract][Full Text] [Related]
17. Double-negative T cells have a reparative role after experimental severe ischemic acute kidney injury.
Lee K; Gharaie S; Kurzhagen JT; Newman-Rivera AM; Arend LJ; Noel S; Rabb H
Am J Physiol Renal Physiol; 2024 Jun; 326(6):F942-F956. PubMed ID: 38634135
[TBL] [Abstract][Full Text] [Related]
18. Caspase-3-dependent peritubular capillary dysfunction is pivotal for the transition from acute to chronic kidney disease after acute ischemia-reperfusion injury.
Lan S; Yang B; Migneault F; Turgeon J; Bourgault M; Dieudé M; Cardinal H; Hickey MJ; Patey N; Hébert MJ
Am J Physiol Renal Physiol; 2021 Sep; 321(3):F335-F351. PubMed ID: 34338031
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine attenuates renal fibrosis via α2-adrenergic receptor-dependent inhibition of cellular senescence after renal ischemia/reperfusion.
Li Q; Chen C; Chen X; Han M; Li J
Life Sci; 2018 Aug; 207():1-8. PubMed ID: 29729264
[TBL] [Abstract][Full Text] [Related]
20. Caspase-3 Is a Pivotal Regulator of Microvascular Rarefaction and Renal Fibrosis after Ischemia-Reperfusion Injury.
Yang B; Lan S; Dieudé M; Sabo-Vatasescu JP; Karakeussian-Rimbaud A; Turgeon J; Qi S; Gunaratnam L; Patey N; Hébert MJ
J Am Soc Nephrol; 2018 Jul; 29(7):1900-1916. PubMed ID: 29925521
[No Abstract] [Full Text] [Related]
[Next] [New Search]
